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Measured and calculated variables of global oxygenation in healthy
neonatal foals
Abstract
OBJECTIVE To assess multiple central venous and arterial blood variables that alone o r in conjunction with
one another reflect global oxygenation status in healthy neonatal foals.
ANIMALS 11 healthy neonatal foals.
PROCEDURES Central venous and arterial blood samples were collected from healthy neonatal foals at 12,
24, 36, 48, 72, and 96 hours after birth. Variables measured from central venous and arterial blood samples
included oxygen saturation of hemoglobin, partial pressure of oxygen, lactate concentration, partial pressure
of carbon dioxide, and pH. Calculated variables included venous-to-arterial carbon dioxide gap, estimated
oxygen ext raction ratio, ratio of partial pressure of oxygen in arterial blood to the fraction of inspired oxygen,
bicarbonate concentration, base excess, and blood oxygen content.
RESULTS Significant differences between arterial and central venous blood obtained from neonatal foals
were detected for several variables, particularly partial pressure of oxygen, oxygen saturation of hemoglobin,
and oxygen content. In addition, the partial pressure of carbon dioxide in central venous blood samples was
significantly higher than the value for cor responding arterial blood samples. Several temporal differences were
detected for other variables.
CONCLUSIONS AND CLINICAL RELEVANCE Results of this study provided info rmation about several
variables that reflect global oxygenation in healthy neonatal foals. Values for these variables in healthy foals can
allow for comparison with values for critically ill foals in future studies. Comparison of these variables
between healthy and ill foals may aid in treatment decisions and prognosis of clinical outcome for crit ically ill
foals.
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OBJECTIVE 
To assess multiple central venous and arterial blood variables that alone o r 
in conjunction with one another reflect global oxygenation status in healthy 
neonatal foals. 
ANIMALS 
11 healthy neonatal foals . 
PROCEDURES 
Central venous and arterial blood samples were collected from healthy 
neonatal foals at 12, 24, 36, 48, 72, and 96 hours after birth. Variables 
measured from central venous and arterial blood samples included oxygen 
saturation of hemoglobin, partial pressure of oxygen , lactate concentration, 
partial pressure of carbon dioxide, and pH. Calculated variables included 
venous-to-arterial carbon dioxide gap, estimated oxygen ext raction ratio, 
ratio of partial pressure of oxygen in arterial blood to the fraction of in-
spired oxygen, bicarbonate concentration, base excess, and blood oxygen 
content. 
RESULTS 
Significant differences between arterial and central venous blood obtained 
from neonatal foals were detected for several variables, particularly partial 
pressure of oxygen, oxygen saturation of hemoglobin , and oxygen content. 
In addition , the partial pressure of carbon dioxide in central venous blood 
samples was significantly higher than the value fo r cor responding arteria l 
blood samples. Several temporal differences were detected for other vari -
ables. 
CONCLUSIONS AND CLINICAL RELEVANCE 
Results of this study provided info rmation about several variables that re-
flect global oxygenation in healthy neonatal foals . Values for t hese variables 
in healthy foals can allow for comparison with values for critically ill foals in 
future studies. Comparison of these variables between healthy and ill foals 
may aid in treatment decisions and prognosis of clinical outcome for crit i-
cally ill foals . (Am j Vet Res 20 I 7;78:230-238) 
Shock, broadly defined as a failure to meet cellular metabolic demands, can result from failure of blood delivery or maldistribution of blood flow within the cardiovascular system.1 If hypoperfusion persists, tis-
sue oxygen consumption decreases, which results in 
cellular dysoxia, anaerobic cellular metabolism, cell 
death, and multiorgan dysfunction.1-3 Clinical moni-
toring of shock in critically ill patients encompasses 
evaluation of several subjective and objective assess-
ments and targeted therapeutic decisions to facilitate 
adequate oxygen delivery and restore aerobic cellular 
activity. By improving tissue oxygenation, the risk of 
multiorgan dysfunction, a cause of increased morbid-
ity and mortality rates among hospitalized patients, 
can potentially be avoided.4 Toward this goal , specif-
ic therapeutic endpoints have been used to estimate 
adequacy of resuscitation in shock states, ranging 
from evaluation of noninvasive physical examination 
variables (eg, heart rate, capillary refill t ime, urinary 
output, and mental status) to more invasive measure-
ments (eg, cardiac output and Svo2).5-7 Prospective 
clinical studies support the use of more invasive mon-
itoring to guide early goal-directed therapy in critical-
ly ill people.s,s,9 Those studies were conducted with 
ABBREVIATIONS 
BE Base excess 
BEa Base excess in arterial blood 
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the supposition that early hemodynamic assessment 
based on results of physical examination, vital signs , 
and urinary output would fail to detect persistent 
global tissue hypoxia, as might be observed during 
compensatory shock.1 ·' Conversely, assessment and 
use of Svo2, BE, pH, and arterial lactate concentration 
as therapeutic endpoints are arguably more valuable 
than physical examination variables and might help 
guide specific early goal-directed therapy to more 
effectively manipulate cardiac preload, afterload, 
and contractility to attain optimal balance between 
oxygen delivery and demand."7·10 It was concluded 
that early goal-directed therapy improved patient 
outcome for severe sepsis and septic shock (in-hos-
pital mortality rate with early goal-directed therapy 
was 30.5%, compared with 46.5% without early goal-
directed therapy).5 Interestingly, some follow-up 
studies11 -14 refuted the benefits of invasive monitor-
ing and early goal-directed therapy on the basis of a 
lack of difference in outcomes when protocol-based 
(ie, measurement of Svo2 and early goal-directed ther-
apy) and standard-based resuscitation were used for 
septic shock, which has provided controversy in re-
gard to the benefits of invasive monitoring and early 
goal-directed therapy in critically ill people. 11 -14 
Shock is commonly encountered in neonatal foals, 
primarily as a result of sepsis, but therapeutic endpoints 
in equine medicine are largely reliant on assessment of 
physical examination findings and blood lactate con-
centrations, which may fail to detect suboptimal oxy-
gen delivery.15-18 Although the placement of a catheter 
in a pulmonary artery for measurement of Svo2 is im-
practical in most veterinary clinical settings, neonatal 
foals with sepsis or shock (or both) invariably require 
placement of a catheter in a jugular vein to initiate ap-
propriate treatment. In these instances, a longer (35- to 
40-cm) IV catheter routinely can be inserted to near the 
right atrium and used to collect central venous blood. 
Measurement of oxygen saturation in central venous 
blood is an acceptable replacement for measurement of 
oxygen saturation in mixed venous blood, although it 
overestimates Svo2 by 5%.10,19-22 
Measurement of Scvo2 provides an estimate of 
the amount of oxygen that has been extracted from 
circulating hemoglobin by organs during the return 
of blood to the right side of the heart.19 In addition to 
Scvoz, several other variables investigated as markers 
of global oxygenation in humans may be applicable 
in foals. For example, Pcvco2 - Paco2 has been used 
to guide treatment of shock.19,Z3-25 Carbon dioxide is 
a normal terminal product of oxidative metabolism, 
and, in the absence of a vascular shunt, C02 concen-
trations in the venous blood must be higher than those 
in the arterial blood. 19·23-25 In situations that result in 
anaerobic metabolism from oxygen debt, hydrogen 
ions are generated from hydrolysis of ATP to ADP and 
increased production of lactate.25 Hydrogen ions are 
buffered by bicarbonate present in cells; during this 
process, C02 is produced. 26 The Paco2 is dependent 
on pulmonary gas exchange, whereas Pcvco2 is de-
pendent on blood flow (ie, cardiac output) to remove 
C02 from the tissues.19 An inverse relationship exists 
between cardiac output and Pcvco2 - Pacoz, with in-
creased Pcvco2 - Paco2 suggesting a decrease in blood 
flow. 27·28 Other variables evaluated as markers of glob-
al oxygenation include Po2 or Pco2, blood lactate con-
centration, and 0 2ER as well as blood gas variables 
(pH, bicarbonate concentration, and BE). 26 ·29-31 
A paucity of clinical information currently exists 
with regard to basic global oxygen metabolism dur-
ing sepsis and shock in equine neonates, and an equal 
lack of information exists with respect to monitor-
ing foals with sepsis and shock. The objectives of the 
study reported here were to measure variables associ-
ated with global oxygen status as well as to compare 
results between central venous and arterial samples 
for several variables associated with systemic oxygen-
ation. One or more of the evaluated variables subse-
quently may serve as a method for monitoring global 
oxygenation in ill foals . 
Materials and Methods 
Animals 
Eleven university-owned Thoroughbred and 
Quarter Horse neonatal foals (5 colts and 6 fillies) 
were used in the study. Mean ± SD body weight was 
52 .2 ± 7.6 kg. All foals were considered healthy on the 
basis that the dam had an uncomplicated gestation 
and parturition and that physical examination vari-
ables of the foals were within acceptable limits. Foals 
were excluded if it was determined that they had 
inadequate passive transfer of immunity (serum IgG 
< 800 mg/dL, measured at 24 hours of age). Foals 
were kept with their dams during the entire study 
period; each dam and foal was housed in a box stall 
with access to small individual paddocks. The study 
protocol was reviewed and approved by the Iowa 
State University Institutional Animal Care and Use 
Committee. 
Experimental design and sample 
collection 
When foals were 12 hours old, anesthetic cream 
was topically placed on the lateral aspect of the left 
hind limb over the metatarsea dorsalis III artery. 
Foals then were sedated with diazepam (0.1 mg/kg, 
IV) and placed in right lateral recumbency on a pad-
ded mat. Hair over the left jugular vein was clipped, 
the skin was aseptically prepared, and 1 mL of lido-
caine was administered SC over the jugular vein. A 
16-gauge, 60-cm, single-lumen polyurethane catheter 
with a peel-away introducer" was inserted into the 
jugular vein in the rostral third of the neck. Catheter 
length was estimated before insertion by measuring 
the distance from the catheter insertion site to the 
level of the caudal aspect of the scapula. The catheter 
was advanced until the tip of the catheter was located 
within 1 rib space of the cranial vena cava, which 
was confirmed by evaluation of a lateral thoracic ra-
diograph. If the catheter was in the right atrium or 
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cranial to the cranial vena cava, the catheter was re-
positioned and another radiograph was obtained to 
confirm proper placement. The catheter was held in 
place with sutures, and patency was maintained by 
flushing 5 mL of heparinized saline (0.9% NaCl) solu-
tion through the catheter every 6 to 8 hours. 
Blood samples were collected 10 minutes after 
foals were positioned in lateral recumbency. Approxi-
mately 0.5 to 1 ml of arterial blood was collected by 
use of anaerobic conditions from the metatarsea dor-
salis III artery with a blood gas syringe containing 
lyophilized heparin. Subsequently, 10 ml of central 
venous blood was obtained anaerobically by use of 
the catheter in the cranial vena cava. For the central 
venous sample, ::"'. 3 times the dead space volume of 
the catheter was withdrawn before sample collec-
tion. Approximately 1 ml of the central venous blood 
sample was placed by use of anaerobic conditions 
into a blood gas syringe containing lyophilized hepa-
rin, and the remaining central venous blood was split 
between a tube containing EDTA and a serum separa-
tor tube. The precollection blood was administered 
back to each foal via the IV catheter, and the catheter 
was flushed with heparinized saline solution. Arte-
rial and central venous blood samples were collected 
from each foal at 12, 24, 36, 48, 72, 96, and 120 hours 
after birth. 
Both the central venous and arterial blood sam-
ples were analyzed within 15 minutes after collec-
tion. Blood variables measuredh were Pcvo2, Pao2, 
Scvo2, Sao2, central venous lactate concentration, ar-
teriallactate concentration, Pcvco2, Paco2, central ve-
nous pH, and arterial pH. Variables calculatedb were 
PCVC02 - PaCOz, 02ER, Pao2:FIOz, 02Ctcv, 02Cta, 
HC03cv, HC03a, BEcv, and BEa. Equations used for 
calculation of some of these variables were as fol-
lows: 
0 2ER = (Sao2 - Scvo2)/Sao2 
0 2Ctcv = ([1.39 X hemoglobin concentration] X 
[Scvo2/100]) + (0.0031 X Pcvo2) 
0 2Cta = ([1.39 X hemoglobin concentration] X [Sao2/100]) 
+ (0.0031 X Pao2) 
BEcv = (1 - (0.014 X hemoglobin concentration]) X 
(HC03cv - 24) + (((1.43 X hemoglobin concentration}+ 
7.7] X [central venous pH - 7.4]) 
BEa = (1 - [0.014 X hemoglobin concentration]) X (HC03a 
- 24) + ([(1.43 X hemoglobin concentration}+ 7.7] X 
[arterial pH - 7.4]) 
In addition, 2 other variables were calculated by 
use of the following equations: 
HC03cv - central venous pH = pK + (log10 HC03cv)/ 
(a X Pcvco2) 
HC03a - arterial pH= pK + (log10 HC03a)/(a X Paco2) 
where pK = 6.091 and a (ie, the solubility coefficient 
for C02) = 0 .0307. 
Statistical analysis 
All results were reported as mean ± SD. All mea-
sured and calculated blood variables (responses) were 
analyzed by use of repeated-measures ANOV As. Sample, 
time, and the sample-by-time interaction were used as 
fixed effects, whereas foal was used as the subject of 
the repeated measures. Differences were assessed by 
use of the F test followed by the Tukey t test for multiple 
comparisons. For all analyses, values were considered 
significantly different at P < 0.05. 
Results 
No complications were associated with catheter 
placement or data collection, and vital signs remained 
within acceptable limits in all foals during the experi-
mental period. Mean ± SD length of the central venous 
catheter (from catheter insertion site to the cranial vena 
cava) was 34.8 ± 2.5 cm. The Pao2 and Sao2 were signifi-
cantly higher than the Pcvco2 and Scvo2' respectively, 
at all time points. Furthermore, Pao2 was significantly 
lower at 12, 24, 36, and 48 hours, compared with the 
Pao2 at later times (Table I). The 0 2Cta was significant-
ly higher than the 0 2Ctcv at all time points. 
Table I- Mean± SD values of oxygen saturation, partial pressure of oxygen, and oxygen content for blood samples obtained from 
I I healthy foals at various times during the neonatal period. 
Pcvo2 Pao2 0 2Ctcv 0 2Cta 
Age (h) Scvo2 (%) Sao2 (%) (mm Hg) (mm Hg) (ml of 0 2/dl) (ml of 0 2/dl) 
12 73.9 ± 9.2 92.2 ± 4.7* 40.0 ± 5.3 64.6 ± 11.6* 12.8 ± 2.1 16. I ± 1.8* 
24 76.5 ± 4.8 94.8 ± 1.7* 40.9 ± 4.0 69.9 ± 6.6* 12.3 ± 1.2 16.6 ± 0.9* 
36 75.2 ± 4.6 93.4 ± 5.4* 40.4 ± 3.5 69.3 ± 12.3* 12.4 ± 1.2 I 5.5 ± 1.3* 
48 74.8 ± 4.5 95.I ± 1.8* 40.9 ± 3.3 72.1 ± 7.7*t 12.9 ± 1.7 16.5 ± 3.6* 
72 74.1 ± 5.1 96.5 ± 1.3* 40.1 ± 3.8 78.8 ± 8.8*W 11 12.2 ± 1.4 16.3 ± 1.6* 
96 73.1 ± 8.9 96.3 ± 1.7* 39.9 ± 6.0 78.2 ± 7.9*H§ 11.9 ± 1.7 16.3 ± 1.7* 
120 73.7 ± 6.9 96.5 ± 1.2* 39.8 ± 3.9 78.4 ± 5.9*H§ II 12.0 ± 2.0 16.1 ± 1.2* 
All ages 74.5 ±I.I 95.0 ± 1.7 40.2 ± 0.6 12.4 ± 0.4 16.2 ± 0.4 
When there was no significant (P 2'. 0.05) effect of time on a variable, the mean value over time (all ages) was calculated. 
*Within a row, value differs significantly (P < 0.05) from the corresponding value for the central venous variable. tWith in a column, value dif-
fers significantly (P < 0.05) from the value at 12 hours. tWithin a column, value differs significantly (P < 0.05) from the value at 24 hours . §Within 
a column, value differs significantly (P < 0.05) from the value at 36 hours. II Within a column, value differs significantly (P < 0.05) from the value at 
48 hours. 
- = Not determined. 
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Table 2-Mean ± SD values of various measured and calculated variables for blood samples obtained from I I healthy foals at 
various times during the neonatal period. 
Pcvco2 Paco 2 Pcvco2 - Paco2 0 2ER (%) Lactate-cv Lactate-a 
Age (h) (mm Hg) (mm Hg) (mm Hg) (mm Hg) (mmol/L) (mmol/L) Pao2:F102 
12 45.2 ± 2.9 42.4 ± 2.9* 2.9 ± 2.2 19.8 ± 9.6 2.5 ± 0.9 2.5 ± 0.9 300 ± 57 
24 42.8 ± 3.5 39.4 ± 2.9* 3.6 ± 2.9 19.3 ± 4.5 1.5 ± 0.3t 1.6 ± 0.3 336 ± 34 
36 44.4 ± 3.8 41.3 ± 4.0* 4.1 ± 1.9 19.2 ± 7.0 1.4 ± 0.3t 1.4 ± 0.4t 332 ± 59 
48 45.6 ± 3.4 41.0 ± 3.0* 4.6 ± 2.1 20.9 ± 3.8 1.4 ± 0.4t 1.4 ± 0.5t 345 ± 37 
72 46.2 ± 2.8 40.8 ± 2.8* 5.3 ± 1.4 22.4 ± 4.3 1.6 ± 0.7 1.7 ± 0.7 376 ± 42H 
96 44.2 ± 2.5 38.8 ± 2.9*t 5.4 ± 3.0 24.1±9.2 1.5 ± 0.6t 1.5 ± 0.4t 374 ± 38H 
120 43.9 ± 3.5 38.5 ± 2.4*t 5.4 ± 3.0 23.6 ± 6.8 1.4 ± 0.2t 1.4 ± 0.2t 375 ± 28H 
All ages 44.6 ± I.I 4.5 ± 1.0 21.3 ± 2.0 
Lactate-a = Arterial lactate concentration. Lactate-cv = Central venous lactate concentration. 
See Table I for remainder of key. 
Table 3-Mean ± SD values of BE, bicarbonate concentration, and pH for blood samples obtained 
from I I healthy foals at various times during the neonatal period. 
BEcv BEa HC03cv HC03a 
Age (h) (mEq/L) (mEq/L) (mmol/L) (mmol/L) pHcv pHa 
12 5.1 ± 1.9 4.5 ± 1.8 29.6 ± 2.0 
24 4.7 ± 2.2 3.7 ± 2.0 28.8 ± 2.3 
36 5.0 ± 2.1 3.9 ± 2.0 29.3 ± 2.3 
48 4.7 ± 1.6 3.9 ± 1.8 29.3 ± 2.0 
72 5.3 ± 2.4 4.3 ± 2.6 30.0 ± 2.5 
96 4.2 ± 2.1 3.4 ± 2.0 28.6 ± 2.1 
120 4.1 ± 1.7 3.4 ± 1.9 28.5 ± 1.9 
All ages 4.7 ± 0.4 3.9 ± 0.4 29.2 ± 0.6 
pHa = Arterial pH. pHcv = Central venous pH. 
See Table I for remainder of key. 
The Pao2:F10 2 was significantly higher at 72 , 96, 
and 120 hours, compared with the value at 12 or 
24 hours (Table 2) . There was no significant dif-
ference between arterial and central venous lactate 
concentrations at any time point. The arterial lactate 
concentration was significantly higher at 12 hours, 
compared with the arterial lactate concentration at 
36, 48, 96, and 120 hours. The central venous lactate 
concentration was significantly higher at 12 hours , 
compared with the central venous lactate concentra-
tion at 24, 36, 48, 96, and 120 hours. At all times, 
Pcvco2 was significantly higher than the correspond-
ing Paco2 . The Paco2 was significantly higher at 12 
hours, compared with Paco2 at 96 and 120 hours. No 
significant differences in Pcvco2 - Paco2 or 0 2ER were 
detected at any time. 
Central venous pH was significant ly lower than 
arterial pH at 48, 72 , 96, and 120 hours . The HC03cv 
was significantly higher than HC03a at 96 hours (Table 3) . 
There was no significant effect of time on Pcv-
COz, 0 2Ctcv, 0 2Cta, Scvo2 , Sao2 , Pcvco2 , Pcvco2 -
Paco2 , 0 2ER, central venous pH, arterial pH, HC03cv, 
HC03a, BEcv, and Bea. Therefore, a mean value over 
time for each variable was calculated (Tables 1-3). 
Discussion 
Clinical and hemodynamic variables such as 
heart rate, blood pressure, urine output, and central 
venous pressure can be unreliable or late indicators 
28.6 ± 2.1 7.422 ± 0.024 7.433 ± 0.015 
27.3 ± 2.1 7.432 ± 0.025 7.445 ± 0.024 
27.8 ± 2.3 7.425 ± 0.022 7.433 ± 0.022 
27.8 ± 2.0 7.416 ± 0.025 7.435 ± 0.0 17* 
28.1 ± 2.7 7.416 ± 0.022 7.44 1 ±0.021 * 
26.6 ± 2.6* 7.415 ± 0.020 7.452 ± 0.032* 
26.7 ± 2.3 7.418 ± 0.02 1 7.459 ± 0.020* 
27.6 ± 0.7 7.42 1 ± 0.006 7.442 ± 0.0 I 0 
of inadequate tissue perfusion and, in some situa-
tions, may provide limited guidance for timely treat-
ment.30 In the study reported here , investigation into 
the use of central venous and arterial blood variables 
associated with global oxygenation in healthy neona-
tal foals was conducted to establish baseline values . 
The subsequent objective will be to comp are similar 
global oxygen variables for ill foals, with the inten t 
of improving treatment and the ability to determine 
prognosis in situations such as sepsis and septic 
shock in neonatal foals . 
In the present study, placement of a central venous 
catheter into the cranial vena cava in healthy neonatal 
foals was technically easy to accomplish, and the cath-
eter was easy to maintain for the 5-day study period. 
Inflammation or skin irritation was not detected at the 
catheter insertion site, and adverse effects attributable 
to catheter placement were not encountered. 
Mean body weight of the foals was 52.2 kg, and 
the mean length of the catheter from the insertion 
site to the cranial vena cava was 34.8 cm. Ideally, 
catheter placement in the cranial vena cava should be 
confirmed with radiography; however, if radiography 
is not available, we suggest (on the basis of subjec-
tive observation) that length of the catheter to reach 
the cranial vena cava can be reasonably estimated by 
measuring the distance from the catheter insertion 
site to the caudal aspect of the scapula. 
The Svo2 reflects the amount of oxygen remain-
ing in blood in the pulmonary artery, including blood 
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from the cranial and caudal vena cava, coronary si-
nuses, and right side of the heart, after all the tissues 
of the body have consumed oxygen, and it is a repre-
sentative index of global tissue oxygenation.32-35 The 
Svo2 has been used in critical care settings for people 
to aid in treatment decisions (eg, assessing resuscita-
tion, cardiac function , and systemic oxygen balance) 
as well as for determining a prognosis.32-35 Moreover, 
assessment and monitoring of Svo2 can be more reli-
able than the use of physical examination variables in 
patients with compensated shock, whereby noninva-
sively measured variables can fail to detect the pres-
ence or severity of shock.36-39 However, collection of 
mixed-venous blood samples requires placement of 
a catheter in a pulmonary artery, which traverses 2 
heart valves. This procedure is invasive and techni-
cally challenging and can be associated with com-
plications, including catheter-associated infections, 
increased risk of arrhythmias, and, rarely, rupture of 
the pulmonary artery.40 Thus, measurement of Svo2 
has become less popular in the human critical care 
field. 35,40 
In contrast, measurement of Scvo2 in samples ob-
tained from the cranial vena cava has been advocated 
as a surrogate for Svo2.41 ·42 The main factors that influ-
ence Scvo2 are the concentration of hemoglobin, Sao2, 
cardiac output, and oxygen consumption. Theoreti-
cally, if hemoglobin concentration, Sao2 , and oxygen 
consumption are kept constant, Scvo2 reflects cardiac 
output. 24 In healthy people, Scvo2 ranges from 73% 
to 82% , with a high or low Scvo2 suggestive of poten-
tial pathological conditions.19 A low Scvo2 indicates 
increased oxygen extraction from hemoglobin and 
typically suggests inadequate oxygen delivery or in-
creased oxygen consumption, whereas a high Scvo2 
can result from impaired oxygen utilization and may 
represent an inability of cells to extract oxygen, mi-
tochondrial defects, or microcirculatory shunting in 
sepsis.19,35.43-46 Evaluation of blood lactate concentra-
tions and Pcvco2 - Paco2 may help differentiate the 
underlying cause of alterations in Scvo2 .19.23·24 
In the study reported here, no significant differ-
ence in Scvo2 was detected during the experimental 
period (12 to 120 hours); mean ± SD Scvo2 over all 
times was 74.5 ± 1.1% (range, 52% to 87%). Mean val-
ues of Scvo2 in healthy neonatal foals were similar 
to those measured in healthy people (76 ± 6%).47 In 
humans with sepsis, a target treatment endpoint of 
Scvo2 > 70% has been suggested, but prospective tri-
als in ill foals will be necessary to evaluate the use of 
Scvo2 as a treatment endpoint.5•48 In dogs with exper-
imentally induced hypovolemia, low or decreasing 
Scvo2 and high or increasing Pcvco2 - Paco2 were de-
tected after administration of furosemide, which re-
flected changes in global oxygen balance and altered 
microcirculatory blood flow in hypovolemia.24 As 
expected in the present study, Sao2 was significantly 
higher at all times than was Scvo2; mean Sao2 over 
all times was 95 ± 1.7% , which is similar to measure-
ments in healthy neonatal foals reported elsewhere.49 
In relation to Scvo2 and Sao2, values for the partial 
pressure of oxygen in mixed-venous blood in recum-
bent neonatal (birth to 14 days of age) foals have been 
reported, with a mean ± SD value of 40.5 ± 05 mm Hg 
over the 14-day study period.50 Mean Pcvco2 reported 
in the present study (40.2 ± 0.6 mm Hg) for central 
venous blood was similar to that previously reported 
for mixed-venous blood.5° In the present study, mean 
Pao7 was significantly lower at 12 hours, compared 
with the Pao2 at several later time points (ie , 48, 72, 
96, and 120 hours). This pattern has been observed 
in other studies and is attributed to the change in gas 
exchange efficiency that developmentally occurs in 
foals during the first week after birth.51 
As would be expected in healthy foals , Pcvco2 
was significantly higher than Paco2 during the study 
period, and values were similar to Pco2 measured in 
samples obtained from the pulmonary vein of neona-
tal foals5° and healthy adult dogs.52 The Pcvco2 - Paco2 
has been used as a marker of global hemodynamic 
status and might have use for the detection of low 
blood flow states in ill neonatal foals .23 An increase 
in Pcvco2 results when cellular oxidation overwhelms 
the body's buffering systems.41 Although Paco2 is vari-
able and dependent on pulmonary gas exchange, 
Pcvco2 is dependent on blood flow (ie, cardiac output) 
to remove C02 from tissues.19·41 Thus, an increase in 
Pcvco2 - Paco2 can reflect decreased blood flow and 
has been reported in critically ill humans with severe 
sepsis, heart failure , hypovolemia, or other low-flow 
states.27·28·41 ·5354 The complementary use of Scvo2 and 
Pcvco2 - Paco2 has been recommended for conditions 
in which oxygen uptake is insufficient because of 
microcirculatory or mitochondrial defects (ie, severe 
sepsis) that result in a falsely elevated Scvo2; in this 
situation, an increase in Pcvco2 - Paco2 may help cli-
nicians detect inadequate oxygen delivery. 19 No dif-
ference in Pcvco2 - Paco2 was noted over time in the 
healthy foals of the present study; mean ± SD Pcvco2 
- Paco2 over all times was 4.5 ± 1.0 mm Hg, which 
is similar to the Pcvco2 - Paco2 in healthy people 
(< 5 mm Hg) and healthy dogs (5.8 mm Hg).26.28,52-54 
The 0 2ER is the amount of oxygen removed 
from the blood by the tissues . Oxygen extraction 
increases in situations of decreased oxygen delivery 
(ie , shock), tissue hypoxia, or lactic acidosis or as 
a result of increased metabolic demand .31 A strong 
negative correlation between 0 2ER and Scvo2 has 
been detected in humans : as hemoglobin becomes 
more desaturated, an increase in oxygen extraction 
occurs, which results in a decrease in Scvo2.31 When 
oxygen delivery decreases below the threshold to 
maintain oxygen consumption via increased oxygen 
extraction, consumption becomes delivery depen-
dent and tissues begin to produce lactate, with lactic 
acidosis typically accompanying an 0 2ER > 50%.10·31 
Conversely, a decrease in 0 2ER can be observed if 
tissue oxygen consumption decreases or if tissues 
cannot use oxygen; this situation may be associated 
with an abnormal increase in Scvo2.31 If the tissues 
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are not capable of extracting oxygen (ie, shunting of 
blood or cell death), venous blood may have a high 
oxygen content despite persistent cellular hypox-
ia.35 The 0 2ER has also been used to help identify 
patients with fatal conditions, especially those with 
Scvo2 > 70%.31 The mean 0 2ER for all times in the 
foals of the study reported here was 21.3%, which is 
comparable to that reported for dogs55 (20.5%) and 
healthy people31 (25%). 
Lactate is the end product of glycolysis, with the 
arterial lactate concentration historically used as the 
reference value for assessment of tissue hypoxia or 
dysoxia.56 However, it has been suggested56-58 that ve-
nous and arterial lactate concentrations can be used 
interchangeably. Venous blood samples can typically 
be collected more rapidly and are technically easier to 
collect, compared with arterial blood samples, which 
has spurred investigation of the suitability of venous 
blood lactate concentrations as an early indicator of 
sepsis.56.58 In I study,58 the mean difference between ve-
nous and arterial lactate concentrations in people was 
0.54 mmol/L, which suggests that lactate concentra-
tions in peripheral venous blood can be an appropriate 
substitute in septic patients. In another study,56 inves-
tigators found a strong correlation (r = 0.96) between 
arterial and peripheral venous blood lactate concentra-
tions, with venous blood lactate concentrations more 
effective than arterial lactate concentrations for use 
in detecting severe sepsis. Other investigators com-
pared central venous and arterial blood lactate con-
centrations and reported a mean difference in cen-
tral venous-to-arterial lactate concentrations of 0.08 
mmol/L.59 Conversely, a difference between arterial 
and venous lactate concentrations has been found 
(mean venous lactate concentration was 1.1 mmol/L 
higher than the corresponding arterial lactate con-
centration in people admitted to an emergency de-
partment).57 In comparison, a slightly higher arterial 
lactate concentration, compared with the venous 
blood lactate concentration, was detected in people 
with sepsis.56 In the study reported here, the cen-
tral venous lactate concentration was comparatively 
similar to values for peripheral venous samples ob-
tained from healthy foals.60 A significant difference 
was not detected between the central venous and 
arterial lactate concentrations in the present study, 
which suggested that central venous and arterial lac-
tate concentrations can be used interchangeably for 
healthy neonatal foals. Both arterial and venous lac-
tate concentrations have been evaluated in neonatal 
foals w ith sepsis16-18 ; however, to our knowledge, no 
studies have been conducted to compare peripheral 
venous or central venous lactate concentrations with 
arterial lactate concentrations in ill foals. 
Studies61 ·62 have also detected a relationship be-
tween the degree of acidosis and mortality rates in 
critically ill patients. Blood pH is commonly evalu-
ated during blood gas analysis and is a cornerstone 
for assessment of acid-base status. In contrast to pH 
values measured in adult horses,63 in which no differ-
ence was detected between venous and arterial pH, 
the foals of the study reported here had a significantly 
lower central venous pH, compared with the arteri-
al pH, at 48, 72, 96, and 120 hours. Other variables 
have been used to assess hemodynamic failure. For 
example, inadequate oxygen delivery to tissues dur-
ing sepsis or other conditions associated with hypo-
perfusion may be identified by an increase in lactate 
concentrations, but a number of unmeasured acidic 
compounds can also be present during these condi-
tions and perhaps better detected by assessment of 
BE or serum HC03 concentration.c Base excess has 
been used as a marker of tissue perfusion and adequa-
cy of resuscitation as well as a predictor of mortality 
rates.64,c Low (more negative) BE values at admission 
have been associated with higher mortality rates , and 
improvement of BE in patients with severe sepsis and 
septic shock has been a strong predictor of a better 
outcome.64,c In addition, BE has been suggested as a 
surrogate for blood lactate concentration when a lac-
tometer is not available, with BE -4 mEq/L correlat-
ing with a lactate concentration > 3 mmol/L.6' In 1 
study16 involving ill neonatal foals , BE < 3.9 mEq/L 
predicted hyperlactatemia (lactate concentration > 5 
mmol/L) with good sensitivity and specificity. 
Base excess also has been used as an indicator of 
metabolic acid-base disturbances.29 In the study re-
ported here, a significant difference between BEcv 
and BEa was not detected, with mean values of 4.7 
and 3.9 mmol/L, respectively. In addition to BE, se-
rum HC03 concentrations have also been suggested 
as a method for evaluation of acid-base status as well 
as a surrogate for BE.29·66 Measurement of serum 
HC03 concentration is more readily available because 
these concentrations are routinely measured during 
serum biochemical analysis, whereas blood gas analy-
sis is not always available. In studies29·66 that involved 
evaluation of human patients in intensive care units, 
serum HC03 concentration had a strong correlation (r = 0.857) with BE and was a reliable indicator of 
metabolic acidosis . In many ways, these variables 
(lactate concentration, BE, and HC03 concentration) 
are different facets of the same process (ie, pertur-
bation of the acid-base equilibrium as a result of the 
nonvolatile acid load originating from dysfunctional 
cells [lactate] or dead cells [intracellular strong acid 
content higher than plasma content]).61 However, de-
pending on the degree of perturbation during criti-
cal illness and availability of diagnostic testing, one 
or more of these specific variables may help guide 
future resuscitation efforts in ill foals and could po-
tentially aid in determining prognosis.64 
The Pao2:F102 was implemented in the 1990s to 
improve standardization of research and criteria for 
more accurate determination of disease severity and 
prognosis as it relates to acute respiratory distress 
syndrome.67 This ratio facilitates evaluation of the re-
spiratory system by comparing Pao2 with the amount 
of inspired oxygen and is part of the inclusion criteri-
on for acute lung injury and acute respiratory distress 
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syndrome.51 ·67-68 Consensus definitions have been 
developed for veterinary use and specifically to ad-
dress acute lung injury and acute respiratory distress 
syndrome in neonatal foals and to account for recog-
nized changes in gas exchange efficiency that occur in 
newborn foals during the first week after birth.51 The 
suggested Pao2 : F102 values in clinically normal animals 
are similar to those in the study reported here, although 
the mean Pao2 :F102 at 24 hours in the present study was 
300 mm Hg, whereas the suggested ratio in the con-
sensus statement was > 350 mm Hg.51 This difference 
may in part have been attributable to the fact that data 
used to calculate Pao2 :F102 in the consensus statement 
were based on values from foals in a standing posi-
tion (compared with recumbent foals in the present 
study) or differences in instrumentation.51 Data for 
the study reported here will help to validate the rec-
ommended consensus values for Pao2 :F102 in neonatal 
foals and provide additional time points (36, 72, and 
120 hours) for evaluation of Pao2 :F102 • 
Oxygen content in blood is needed to calculate 
other variables associated with global oxygenation, 
such as oxygen delivery and oxygen consumption. 
In the present study, there was no effect of time on 
0 2Cta and 0 2Ctcv; thus, the mean value over time for 
these 2 variables was 16.2 and 12.4 mL/dL, respec-
tively. These values in healthy foals are similar to, 
but slightly less than, those measured in healthy hu-
mans34 (02Cta, 18 to 20 mL/dL; 0 2Ctcv, 13 to 16 ml/ 
dL) and dogs55 (02Cta, 18.5 mL/dL; 0 2Ctcv, 14.7 mL/ 
dL). Oxygen content is greatly impacted by hemoglo-
bin concentration, which differs among reports. The 
hemoglobin content factor used to estimate hemoglo-
bin oxygen content differs from 1.31 to 1.39, with a 
mid-range value of 1.34 used in many studies; in the 
study reported here, a value of 1.39 was used. 
One limitation of the present study was that only 
11 healthy foals were used to investigate the variables 
associated with systemic oxygenation. Ideally, data for 
a larger number of healthy foals would have been col-
lected. In addition, foals were sedated with diazepam 
at 12 hours of age to facilitate catheter placement. 
Although foals appeared to regain normal mentation 
and activity by the time catheter placement was com-
plete (approx 30 to 45 minutes), it is possible that re-
sidual effects of diazepam may have impacted some 
of the variables to a slight degree. Finally, it has been 
reported50·69 that collection of blood from recumbent 
foals alters results for some of the variables ( eg, venous 
partial pressure of 0 2 , venous partial pressure of COio 
and Pao2) . In the study reported here, both central ve-
nous and arterial blood samples were collected while 
foals were recumbent because this would most likely 
be the position of ill foals in a clinical situation. In ad-
dition, collection of arterial blood samples from a foal 
in a standing position would be extremely difficult. 
Despite these limitations, this study provided values 
for central venous and arterial blood variables that can 
be used for comparison with measurements obtained 
in future research investigations and clinical patients. 
Many of the variables investigated in this report inter-
act or impact one another; thus, it is unlikely that a 
single variable will be a panacea. However, future in-
vestigation and use of one or more of these variables 
for ill foals may facilitate early detection of critical 
clinical conditions (ie, shock or sepsis), help guide 
treatment decisions (eg, when to initiate provision of 
supplemental oxygen, vasopressors, or IV fluids), and 
provide prognostic information. 
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tality in severe sepsis and septic shock evaluated by base ex-
cess variation (abstr). Crit Care 2003;7(suppl 3):39. 
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